1. Cipla to acquire Ivia Beaute's cosmetics, personal care distribution and marketing business for INR 130 crore (~US$15.6 Million).
2. Piramal Group arm invests INR 110 crore (~US$13.2 Million) in Biodeal Pharma.
3. Biocon partners with Biomm to commercialise diabetes drug in Brazil.
4. Bharat Biotech and Netherland based Bilthoven Biologicals (owned by Serum Institute of India) collaborate for oral polio vaccines production, supply.
5. Dr Reddy’s, Bayer join hands to roll out 2nd brand of heart failure drug Vericiguat in India.
6. Nestle India, Dr Reddy's form JV to bring innovative nutraceutical brands to India.
7. Mitsui and Rohto to buy Chinese medicines company Eu Yan Sang for US$594 Million.
8. Bristol Myers signs US$380 Million CAR-T therapies supply deal with Cellares.
9. Genmab to acquire ProfoundBio.
10. Oncopeptides collaborates with Vector Pharma FZCO.
11. Cyxone has entered a collaboration University of Glasgow, for performing an exploratory phase 2 study with rabeximod in patients with rheumatoid arthritis.
12. BioInvent International has announced a clinical trial collaboration and supply agreement with MSD International Business for a Phase 1/2a study of its monoclonal antibody BI-1910 in combination with KEYTRUDA.
Aagami Updates:
1. Aagami is excited to attend the BIO International Convention 2024 in San Diego (June 3-6). Please submit meeting requests through the partnering system or send us an email. 20+ meetings already booked and few options in calendar still open.
2. Aagami new offering: AI/ML Powered Business Intelligence via Analytics. For faster and better decisions with more confidence leading to huge savings in time, effort, and cost, while propelling business growth. Delivered via Specialist partner.